| 臺北醫學大學 |
2011 |
Tumor size as a prognostic factor in resected small hepatocellular carcinoma: A controversy revisited
|
YL, Chen;CJ, Ko;SY, Chien;LS, Chen;ML, Chen;CW, Chi;HW, Lai |
| 臺北醫學大學 |
2011 |
Tumor size as a prognostic factor in resected small hepatocellular carcinoma: A controversy revisited
|
Chen, YL;Ko, CJ;Chien, SY;Chen, LS;Chen, ML;Chi, CW;Lai, HW |
| 大葉大學 |
2016-10 |
Tumor Size Has a Time-Varying Effect on Recurrence in Cervical Cancer
|
Chang, Chung;Chen, Jiabin;Chiang, An Jen |
| 國立臺灣大學 |
2015 |
Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma
|
Huang, Wei-Ju; Jeng, Yung-Ming; Lai, Hong-Shiee; Sheu, Fang-Yu Bonnie; Lai, Po-Lin; Yuan, Ray-Hwang; 鄭永銘; 袁瑞晃; 賴寶蓮; 賴鴻緒 |
| 臺大學術典藏 |
2018-09-10T15:18:54Z |
Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma
|
Huang, W.-J. and Jeng, Y.-M. and Lai, H.-S. and Sheu, F.-Y.B. and Lai, P.-L. and Yuan, R.-H.; RAY-HWANG YUAN; YUNG-MING JENG; HONG-SHIEE LAI |
| 臺大學術典藏 |
2019-11-28T05:38:17Z |
Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma
|
Huang W.-J.;Jeng Y.-M.;Lai H.-S.;Sheu F.-Y.B.;Lai P.-L.;Ray-Hwang Yuan; Huang W.-J.; Jeng Y.-M.; Lai H.-S.; Sheu F.-Y.B.; Lai P.-L.; RAY-HWANG YUAN |
| 臺大學術典藏 |
2020-02-24T05:13:04Z |
Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma
|
Huang W.-J.; Jeng Y.-M.; HONG-SHIEE LAI; Sheu F.-Y.B.; Lai P.-L.; Yuan R.-H. |
| 臺大學術典藏 |
2020-03-06T08:24:59Z |
Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma
|
Huang W.-J.;Yung-Ming Jeng;Lai H.-S.;Sheu F.-Y.B.;Lai P.-L.;Yuan R.-H.; Huang W.-J.; YUNG-MING JENG; Lai H.-S.; Sheu F.-Y.B.; Lai P.-L.; Yuan R.-H. |
| 國立成功大學 |
2007-08 |
Tumor size is a major determinant of recurrence in patients with resectable gastrointestinal stromal tumor
|
Hsu, Kai-Hsi; Yang, Ta-Ming; Shan, Yan-Shen; Lin, Pin-Wen |
| 臺大學術典藏 |
2020-12-02T02:34:18Z |
Tumor size matters differently in pulmonary adenocarcinoma and squamous cell carcinoma
|
Lin P.-Y.;Chang Y.-C.;Chen H.-Y.;Chen C.-H.;Tsui H.-C.;Pan-Chyr Yang; Lin P.-Y.; Chang Y.-C.; Chen H.-Y.; Chen C.-H.; Tsui H.-C.; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-03-19T06:57:49Z |
Tumor size matters differently in pulmonary adenocarcinoma and squamous cell carcinoma
|
Lin P.-Y.;Yeun-Chung Chang;Chen H.-Y.;Chen C.-H.;Tsui H.-C.;Yang P.-C.; Lin P.-Y.; YEUN-CHUNG CHANG; Chen H.-Y.; Chen C.-H.; Tsui H.-C.; Yang P.-C. |
| 中山醫學大學 |
2021 |
Tumor subsites and risk of osteoradionecrosis of the jaw in patients with oral cavity cancer: a national-based cohort study
|
Liao, PH; Chu, CH; Hung, YM; Tang, PL; Kuo, TJ |
| 國立成功大學 |
2021 |
Tumor subsites and risk of osteoradionecrosis of the jaw in patients with oral cavity cancer: a national-based cohort study
|
Liao, P.-H.;Chu, Chu C.-H.;Hung, Y.-M.;Tang, P.-L.;Kuo, T.-J. |
| 國立臺灣大學 |
2007 |
Tumor Suppressor Activity of Ccaat/Enhancer Binding Protein Alpha Is Epigenetically down-Regulated in Acute Myeloid Leukemia
|
李承曄; 田蕙芬; 胡忠怡; 唐季祿; 林亮音; LEE, CHENG-YEH; TIEN, HWEI-FANG; HU, CHUNG-YI; TANG, JIH-LUH; LIN, LIANG-IN |
| 國立臺灣大學 |
2016 |
Tumor suppressor death-associated protein kinase inhibits Th17 by targeting cytoplasmic HIF-1 alpha for degradation
|
Chou, T. -F; Chuang, Y. -T; Hsieh, W. -C; Chang, P. -Y; Hsu, T. -S; Miaw, S. -C; Chen, R. -H; Kimchi, A.; Lai, M. -Z; 繆希椿 |
| 國立臺灣大學 |
2011 |
Tumor Suppressor Death-Associated Protein Kinase Is Required for Full Il-1 Beta Production
|
莊雅婷; 周定芳; 吳佩容; 陳瑞華; 賴明宗; CHUANG, YA-TING; CHOU, TING-FANG; WU, PEI- RUNG; CHEN, RUEY-HWA; LAI, MING-ZONG; LAI, MING- ZONG |
| 臺北醫學大學 |
2014 |
Tumor suppressor FOXO3 regulates ribonculeotide reductase subunit RRM2B and impacts on survival of cancer patients
|
Cho, EC;Kuo, ML;Liu, X;Yang, L;Hsieh, YC;Wang, J;Cheng, Y;Yen, Y |
| 臺北醫學大學 |
2014 |
Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients
|
EC, Cho;ML, Kuo;Liu, X;Yang, L;YC, Hsieh;Wang, J;Cheng, Y;Yen, Yen Y |
| 臺北醫學大學 |
2014-07 |
Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients
|
卓爾婕; Er-Chieh Cho, Mei-Ling Kuo, Xiyong Liu, Lixin Yang, Yi-Chen Hsieh, Jinghan Wang, Yawen Cheng, Yun Yen |
| 臺北醫學大學 |
2014 |
Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients
|
Cho, EC;Kuo, ML;Liu, X;Yang, L;Hsieh, YC;Wang, J;Cheng, Y;Yen, Y |
| 國家衛生研究院 |
2019-09-01 |
Tumor suppressor gene glycine N-methyltransferase and its potential in liver disorders and hepatocellular carcinoma
|
Chen, M;Yang, MH;Chang, MM;Tyan, YC;Chen, YMA |
| 國立成功大學 |
2019 |
Tumor suppressor gene glycine N-methyltransferase and its potential in liver disorders and hepatocellular carcinoma
|
Chen, M.;Yang, M.-H.;Chang, M.-M.;Tyan, Y.-C.;Chen, Y.-M.A. |
| 臺大學術典藏 |
2020-06-17T03:01:55Z |
Tumor suppressor HLJ1 binds and functionally alters nucleophosmin via activating enhancer binding protein 2α complex formation
|
Chang T.-P.;Sung-Liang Yu;Lin S.-Y.;Hsiao Y.-J.;Chang G.-C.;Yang P.-C.;Chen J.J.W.; Chang T.-P.; SUNG-LIANG YU; Lin S.-Y.; Hsiao Y.-J.; Chang G.-C.; Yang P.-C.; Chen J.J.W. |
| 臺大學術典藏 |
2020-12-02T02:34:18Z |
Tumor suppressor HLJ1 binds and functionally alters nucleophosmin via activating enhancer binding protein 2α complex formation
|
Chang T.-P.;Yu S.-L.;Lin S.-Y.;Hsiao Y.-J.;Chang G.-C.;Pan-Chyr Yang;Chen J.J.W.; Chang T.-P.; Yu S.-L.; Lin S.-Y.; Hsiao Y.-J.; Chang G.-C.; PAN-CHYR YANG; Chen J.J.W. |
| 國立臺灣大學 |
2010-02 |
Tumor suppressor HLJ1 switches the double-faced role of nucleophosmin through AP-2α complex formation
|
Chang, Tzu-Pei; Yu, Sung-Liang; Lin, Sheng-Yi; Hsia, Yi-Jing; Chang, Gee-Chen; Yang, Pan-Chyr; Chen, Jeremy J.W.; 張梓珮; 俞松良; 林聖怡; 蕭乂菁; 張基晟; 楊泮池; 陳健尉 |
